REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 164 filers reported holding REGENXBIO INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $623,275 | -16.9% | 37,866 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $750,264 | +12.6% | 37,532 | +6.5% | 0.00% | 0.0% |
| Q1 2023 | $666,161 | -29.0% | 35,228 | -14.8% | 0.00% | 0.0% |
| Q4 2022 | $937,932 | -16.3% | 41,355 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $1,121,000 | -0.4% | 42,404 | -6.9% | 0.00% | 0.0% |
| Q2 2022 | $1,126,000 | +13.2% | 45,568 | +51.9% | 0.00% | 0.0% |
| Q1 2022 | $995,000 | -81.6% | 29,991 | -89.7% | 0.00% | -83.3% |
| Q4 2016 | $5,422,000 | +32.5% | 292,268 | +0.1% | 0.01% | +50.0% |
| Q3 2016 | $4,091,000 | +74.9% | 292,022 | -0.1% | 0.00% | +33.3% |
| Q2 2016 | $2,339,000 | -25.9% | 292,402 | +0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,158,000 | -43.2% | 292,388 | -13.5% | 0.00% | -40.0% |
| Q4 2015 | $5,558,000 | -27.5% | 338,078 | -4.9% | 0.01% | -37.5% |
| Q3 2015 | $7,668,000 | – | 355,344 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |